, APAC
/Freepik

QBE reports 2% YoY growth in Q1’24’s GWP

Premiums declined by 2% in constant currency.

QBE's gross written premium saw a 2% growth in the first quarter 2024 (Q1’24) compared to the same period last year, both in reported and constant currency terms.

Renewal rate increases of 7.3% were in line with expectations, with reduced rate hikes in certain property and reinsurance lines.

Premiums declined by 2% in constant currency, excluding rate increases, due to lower Crop premiums and property exits in North America and Australia. 

Excluding Crop, Group gross written premium and ex-rate growth was 9% and 3% respectively.

ALSO READ: Pressures mount for less desirable energy insurance placements

Organic growth in Crop is expected to partially offset the impact of lower commodity prices, with estimated Crop gross written premium for FY’24 at ~$3.9B. 

Group claims experience is broadly on track with plan assumptions.

From January to April 2024, the net cost of catastrophe claims totalled ~$300M, compared to QBE's catastrophe allowance for 1H’24 of $609M. Catastrophe costs were driven by storm events, mainly in Australia and North America.

A small amount of prior-year development related to European events in 2023, including the Italian hail event in 3Q23, was recorded in the first quarter.

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.